Leukocyte-Rich vs. Poor PRP: Understanding the Differences and Clinical Implications
Published on January 5, 2025
Key Takeaway
The concentration of leukocytes in platelet-rich plasma (PRP) significantly impacts its biological properties and clinical efficacy, with leukocyte-rich PRP showing enhanced anti-inflammatory and tissue repair potential in certain applications.
Introduction
Platelet-rich plasma (PRP) has emerged as a promising treatment in regenerative medicine, particularly in orthopedics and sports medicine. However, not all PRP preparations are created equal. One of the most significant distinctions lies in the concentration of leukocytes, leading to two main types: leukocyte-rich PRP (LR-PRP) and leukocyte-poor PRP (LP-PRP). This article delves into the differences between these two formulations and their potential clinical implications.
Understanding Leukocyte-Rich vs. Leukocyte-Poor PRP
LR-PRP contains a higher concentration of white blood cells compared to whole blood, while LP-PRP has a reduced leukocyte count. According to Marathe et al. (2022), LR-PRP is predominantly lymphocyte-rich with notable concentrations of other white blood cell subtypes. This composition can significantly influence the biological properties of the PRP.

Biological Properties and Effects
The presence or absence of leukocytes in PRP can lead to different biological effects:
- Inflammatory Response: LR-PRP may induce a stronger initial inflammatory response, which could be beneficial in certain conditions.
- Growth Factor Release: Parrish et al. (2016) found that LR-PRP showed increases in growth factor release upon activation, potentially stimulating greater cell proliferation.
- Antimicrobial Properties: The higher leukocyte content in LR-PRP may provide enhanced antimicrobial effects.
Clinical Applications and Outcomes
The choice between LR-PRP and LP-PRP can impact clinical outcomes:
- Osteoarthritis: Shim et al. (2022) reported that LR-PRP might provide better pain relief and successful outcomes for patients with lateral epicondylitis compared to LP-PRP.
- Tendinopathy: Some studies suggest that LP-PRP may be preferable in tendon healing due to less inflammatory response.
- Muscle Injuries: LR-PRP might be more effective in muscle injury repair due to its higher growth factor content.
Preparation Methods and Standardization
The preparation method significantly influences the final composition of PRP. Caiado et al. (2020) describe a standardized freeze-thawing technique for LP-PRP preparation, highlighting the need for consistent protocols. Standardization is crucial for comparing clinical outcomes across studies and optimizing treatment protocols.

Future Directions and Research Needs
While current research provides valuable insights, several areas require further investigation:
- Optimal leukocyte concentrations for specific conditions
- Long-term effects of LR-PRP vs. LP-PRP
- Standardization of preparation protocols
- Personalized PRP formulations based on patient factors
Conclusion
The debate between leukocyte-rich and leukocyte-poor PRP highlights the complexity of biological therapies. While both formulations show promise in various applications, the optimal choice depends on the specific clinical context. As research progresses, a more nuanced understanding of when to use each type of PRP will emerge, potentially leading to more targeted and effective treatments in regenerative medicine.